Boston, Massachusetts 02130


This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).

Study summary:

The most common traumatic brain injury (TBI)-associated problems are cognitive deficits and neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel neuromodulation intervention, light emitting diodes (LED), for treatment of patients with TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any needles or any form of surgery. LED treatment improves cellular activity of the brain tissue that has been damaged by TBI. Half of the study participants will receive active LED treatment, and a control group will receive sham LED. This study takes place in Boston, Massachusetts: at the VA Boston Healthcare System.


Inclusion Criteria: Inclusion Criteria: - OEF/OIF active-duty personnel or Veterans with history of TBI or blast-exposure - Meets criteria for mild TBI - LOC of 30 min or less - Age: 21-55 - Primary language is English Exclusion Criteria: - Evidence of penetrating head injury - History of previous neurological diagnosis - History of previous psychotic disorder prior to TBI - Hearing or vision impairment



Primary Contact:

Principal Investigator
Yelena Bogdanova, PhD PhD
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Yelena Bogdanova, PhD PhD
Phone: (857) 364-2249

Backup Contact:

Vivian Ho, BS
Phone: (857) 364-4001

Location Contact:

Boston, Massachusetts 02130
United States

Yelena Bogdanova, PhD PhD
Phone: 857-364-2249

Site Status: Recruiting

Data Source:

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.